Nuvectis Pharma, Inc. — Institutional Ownership
Which tracked institutions hold NVCT, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
12
Funds holding
$9162929
Total value held
Buying
7 added/new · 4 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $5909128 | 764441 | -18364 | -2.35% |
| 2 | State Street Corp | $1287169 | 166516 | +11850 | +7.66% |
| 3 | Northern Trust Corp | $960159 | 124212 | +7807 | +6.71% |
| 4 | Goldman Sachs Group Inc | $317889 | 41124 | +14621 | +55.17% |
| 5 | Bank Of New York Mellon Corp | $234332 | 30315 | -1320 | -4.17% |
| 6 | Morgan Stanley | $174451 | 22568 | -5443 | -19.43% |
| 7 | Wells Fargo & Company/Mn | $127814 | 16929 | +9022 | +114.10% |
| 8 | Bank Of America Corp /De/ | $114768 | 14847 | +1377 | +10.22% |
| 9 | Barclays Plc | $24126 | 3121 | — | NEW BUY |
| 10 | Royal Bank Of Canada | $10000 | 1264 | — | NEW BUY |
| 11 | Citigroup Inc | $2915 | 386 | -160 | -29.30% |
| 12 | Pnc Financial Services Group, Inc. | $178 | 23 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.